BioXcel Therapeutics Inc. (BTAI) Statistics & Valuation Metrics - Stocknear

BioXcel Therapeutics Inc.

NASDAQ: BTAI · Real-Time Price · USD
2.70
-0.12 (-4.26%)
At close: Sep 26, 2025, 3:59 PM
2.74
1.48%
After-hours: Sep 26, 2025, 07:44 PM EDT

BioXcel Therapeutics Statistics

Share Statistics

BioXcel Therapeutics has 19.65M shares outstanding. The number of shares has increased by 135.93% in one year.

19.65M
135.93%
84.06%
0.99%
17.82M
167,508
1.72%

Short Selling Information

The latest short interest is 1.44M, so 7.35% of the outstanding shares have been sold short.

1.44M
7.35%
7.54%
1

Valuation Ratios

The PE ratio is -0.25 and the forward PE ratio is -0.92. BioXcel Therapeutics's PEG ratio is 0.

-0.25
-0.92
6.69
19.7
-0.16
-0.21
0
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for BioXcel Therapeutics.

n/a
n/a
n/a
n/a

Financial Position

The company has a current ratio of 1.68, with a Debt / Equity ratio of -1.11.

1.68
1.65
-1.11
-2.33
-1.43
-4.44

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

n/a
n/a
n/a
$61.24K
$-1.61M
37
0.06
3.16

Taxes

n/a
0%

Stock Price Statistics

The stock price has increased by -72.02% in the last 52 weeks. The beta is 0.21, so BioXcel Therapeutics's price volatility has been higher than the market average.

0.21
-72.02%
3.46
3.11
40.25
9,737,930

Income Statement

In the last 12 months, BioXcel Therapeutics had revenue of 2.27M and earned -59.6M in profits. Earnings per share was -23.51.

2.27M
123K
-67.25M
-59.6M
-44.16M
-44.47M
-23.51
Full Income Statement

Balance Sheet

The company has 29.85M in cash and 102.95M in debt, giving a net cash position of -73.09M.

29.85M
102.95M
-73.09M
-650.2M
25.79M
-8.13M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -72.03M and capital expenditures 0, giving a free cash flow of -72.03M.

-72.03M
n/a
-72.03M
-28.41
Full Cash Flow Statement

Margins

Gross margin is 5.43%, with operating and profit margins of -2967.56% and -2630.14%.

5.43%
-2967.56%
-2630.14%
-2630.14%
-1948.85%
-2967.56%
-3178.6%

Dividends & Yields

BTAI does not appear to pay any dividends at this time.

n/a
n/a
n/a
n/a
n/a
n/a
Dividend Details

Analyst Forecast

The average price target for BTAI is $37.5, which is 1288.9% higher than the current price. The consensus rating is "Buy".

$37.5
1288.9%
Buy
5
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

n/a
n/a
n/a
n/a

Stock Splits

The last stock split was on Feb 10, 2025. It was a backward split with a ratio of 1:16.

Feb 10, 2025
backward
1:16

Scores

-42.08
2